Mavios

Mavios provides an AI-native platform designed to industrialize bio-based product manufacturing. The company serves as an intelligence layer for the entire bioprocess lifecycle, enabling teams to ingest fragmented data—including lab records, sensor streams, and technical documents—to create a unified, queryable context. By generating digital twins of bioprocesses, the platform allows for in silico simulations, which help organizations de-risk their scale-up efforts, shorten development cycles, prevent batch failures, and reduce operational costs from initial feedstock hypothesis to commercial production.

The platform is designed to assist teams across various sectors, including pharmaceuticals, food technology, cosmetics, and industrial biotechnology. It supports users through four main stages: discovery, scale-up optimization, technology transfer, and production. By offering techno-economic awareness and auto-drafted experimental protocols, Mavios helps companies move faster and more cost-effectively, addressing the challenges of biocomplexity and the high economic risks associated with failed commercialization batches.